CIMED Projektbidrag 2026-2028
Den vetenskapliga granskningen av CIMED projektansökningar är nu klar. Beslut om tilldelning har fattats av CIMED:s styrelse enligt rekommendation av granskargrupperna.
I årets utlysning av CIMED projektbidrag inkom totalt 175 ansökningar, varav 78 juniora och 97 seniora ansökningar. Antal kvinnliga sökande var 79 och manliga sökande var 96. Följande personer har efter vetenskaplig granskning och beslut av CIMED:s styrelse tilldelats CIMED projektbidrag for 2026-2028:
Junior
Antonios Tzortzakakis: ”Advancing PET Radiopharmaceuticals for Precision Oncology”
Benedikt Strunz: ”A functional atlas of immunosuppression in blood and tissue”
Christina Sandlund: ”Sleep restriction group therapy for insomnia in primary health care: a randomized controlled trial and a process evaluation”
Emilie Wahren Borgström: ”Genetic, immunological and microbiological findings in patients with primary immunodeficiency – new diagnostics and improved treatment strategies: the GIMPID-study”
Fredrik Johansson: ”Restraint, seclusion and forced medication in involuntary psychiatric in-patient care: who are exposed and what follows?”
Ghada Nouairia: ”Developing clinical tools for early detection and risk stratification of biliary tract cancers (BTC)”
Greg Winski: ”Real-Time Prediction of Perioperative Risk Through Artificial Intelligence”
Haidong Yao: ”Uncovering Hypoxia-Adapted T Cell Receptors to Enhance Immunotherapy for Hepatocellular Carcinoma”
Helena Rydell: ”Does SGLT-2 inhibitors improve the prognosis for patients on dialysis?”
Jenny Svedenkrans: ”Is the breast milk good or bad when medications are involved? – Clinical effects in preterm infants exposed to maternal antihypertensive drug treatment through mother’s own milk”
Laila Sara Arroyo Muhr: ”Cervical Cancers Escaping HPV Screening: A Multi-Omics Approach to Tumor Evolution and Viral Persistence”
Long Long Chen: ”Emotion Processing and Regulation in people with Intellectual Disability”
Martin Cornillet: ”Deep proteomic trajectories in Primary Sclerosing Cholangitis for the discovery of new mechanisms driving autoimmunity, liver fibrosis and bowel inflammation”
Miriam Elfström: ”Optimization of cervical cancer prevention through risk-based HPV screening”
Oscar Wiklander: ”Extracellular vesicles-based liquid biopsy and targeted therapy in metastatic cancer”
Peter Saliba Gustafsson: ”Dissecting the genomics and single-cell transcriptome of Metabolic Dysfunction-Associated Fatty Liver Disease: From molecular signatures to therapeutic targets”
Rafael Ceña Diez: ”Approaching a clinical evaluation of a novel natural vaginal microbicide against HIV and sexually transmitted infections”
Ricardo Mesquita: ”Are nerves holding on, or letting muscle go? Tracking motor unit loss and reinnervation in ageing”
Russell Ouellette: ”Precision diagnostics for early detection and treatment of Multiple Sclerosis: Building on unique large-scale real-world-evidence, deep learning and 7 Tesla MRI”
Thomas Poiret: ”Enhancing chimeric antigen receptor (CAR) outcome by refining cell content and starting material quality”
Urban Ekman: ”Improved predictions of sub-groups trajectories of early-stage cognitive impairments in large-scale naturalistic settings”
Senior
Agneta Månsson Broberg: ”Genetic predisposition, new biomarkers and senescence footprint and their impact on cancer therapy-related cardiovascular dysfunction”
Anders Sönnerborg: ”HIV-1 latency and its reactivation in search for functional HIV-1 cure”
Andreas Björklund: ”FasI/IIprövningmedadaptivaNK-celler mot behandlings refraktärt myelodysplastiskt syndrom och akut myeloisk leukemi”
Andreas Lennartsson: ”Targeting resistance to Menin inhibitors in acute myeloid leukemia”
Anna Norrby-Teglund: ”Precision medicine in sepsis: mapping gene signatures to immune responses to enable tailored immunomodulatory therapy in sepsis”
Annika Bergquist: ”Primary sclerosing cholangitis (PSC) – Improvement of the prognosis by statin treatment and increased knowledge of the pathogenesis”
Emmanouil Charitakis: ”Assessment of the effect of catheter ablation on elderly population with atrial fibrillation; a randomized controlled study; The ACE-AF study”
Erika Franzén: ”Motor-cognitive performance in neurological disorders – establishing exercise effects and exploring brain activation”
Eva Hellström-Lindberg: ”From identified molecular targets to improved outcome for patients with myelodysplastic syndromes”
Hannes Hagström: ”Clinical and epidemiological projects to improve management of liver disease”
Joakim Dillner: ”Optimizing elimination of cancer-causing human papillomaviruses”
Juha Kere: ”Prediktion och tidig diagnos av pre-eklampsi”
Kristoffer Månsson: ”From noise to signal: Neural variability as a predictive marker for anxiety, depression, and treatment response”
Michelle Chew: ”The Huddinge Perioperative Haemodynamic Center (HPHC): A Research Platform for Optimizing Haemodynamic Management and Surgical Outcomes”
Miia Kivipelto: ”Personalized multidomain preventive interventions for Alzheimer’s disease and related dementias: FINGER 2.0 and MET-FINGER combination trial platform”
Mikael Rydén: ”Clinical studies of insulin resistance in white adipose tissue-from adipose heterogeneity to precision medicine”
Niklas Björkström: ”Personalizing immunosuppression in organ transplantation via integration of spatial immunology”
Peter Stenvinkel: ”Molecular Profiling and New Treatment Strategies of Vascular Ageing in Chronic Kidney Disease”
Peter Svensson: ”Deciphering HIV-1 Reservoir Dynamics to Achieve ART-Free Long-Term Remission”
Sara Garcia-Ptacek: ”Medication repurposing in dementia: selecting brain-friendly medications and establishing a new indication”
Stephan Mielke: ”Inflammation-induced stress on hematopoietic stem cells favoring secondary myelodysplastic and leukemic transformation after chimeric antigen receptor (CAR) T cell therapy”
Tobias Granberg: ”GlucoCEST-MR för kartläggning av hjärnans ämnesomsättning vid Alzheimers sjukdom: En ny strålningsfri funktionell bildmetod som kan bidra till tidig diagnos, behandling och förbättrad uppföljning”
Uwe Tietge: ”A novel cell-free high density lipoprotein (HDL) function assay for cardiovascular disease risk prediction”
Yenan Bryceson: ”Improving molecular diagnostics for children with severe inborn errors of immunity”
Uppdaterad av:
Lena Berglin 2025-06-24